Private investors: FCPR-FPCI

We apply our knowledge of French SMEs to help private investors who are looking for high-performance and meaningful investments

Private equity accessible to individual investors

  • Through its FCPR (Fonds Communs de Placement à Risque) and FPCI (Fonds Professionnels de Capital Investissement) range of private equity funds, Omnes Capital gives individual investors access to an asset class reserved for institutional investors

Boost portfolio returns

  • Invest in unlisted SMEs that create wealth and employment (bearing in mind that investing in private equity poses a liquidity risk)
  • Subscribe to an investment with high potential in exchange for the risk of capital loss
  • Diversify financial assets and secure tax incentives (sales exempt from capital gains tax) in return for freezing assets over a period of 10 years

Omnes’ expertise

  • 20 years’ experience
  • Rigorous selection of SMEs: high-performance French companies with a leadership position in their sector, genuine growth prospects, solid fundamentals and seasoned management team
  • Reasonable leverage and value creation underpinned by growth in portfolio companies’ net revenues (bearing in mind that this growth may not reflect final fund performance ; any investment presents risks)
  • Strong entrepreneurial culture among management teams, who share the same vision as company executives
  • Direct access to the management team
  • Meetings with portfolio companies entrepreneurs and detailed reporting provided
Key figures
20
years’
experience
..
Dedicated offer
to private investors
NewsRoom
Filters
Display:
Press release
09 May 2019
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
Press release
11 April 2019
NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance

NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance
Press release
09 April 2019
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Publication
Omnes Capital Newsletter no 32
LEOM032_GB.pdf
Press release
03 April 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
AgomAb Therapeutics Completes Euros 21m Series A Financing
Press release
19 March 2019
Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy

Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy
Press release
13 March 2019
Therapixel secures a €5 million Series A financing and strengthens its governance
Therapixel secures a €5 million Series A financing and strengthens its governance

Pages